Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FYP81
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,116
Award facts
- Contract value 100% obligated
- $12,115.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 20, 2025, for the supply of Jakafi 10 mg tablets (60-count). The award was made without a set-aside designation, enabling DMS Pharmaceutical Group to compete on an open basis leveraging its established status as a woman-owned small business. Performance is scheduled for completion by August 21, 2025, with the delivery location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending through November 2026. The parent contract, established under the SPE2DB program, authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities nationwide. Jakafi, a prescription medication used in the treatment of myelofibrosis and polycythemia vera, represents the type of specialty pharmaceutical product DMS Pharmaceutical Group routinely supplies to federal healthcare systems through this broad-based pharmaceutical supply vehicle.
Quick answers
Who was awarded contract SPE2DB25FYP81?
SPE2DB25FYP81 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FYP81 worth?
The government has obligated $12,116 on SPE2DB25FYP81.
Is contract SPE2DB25FYP81 an order under another contract?
Yes. SPE2DB25FYP81 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP81 competed?
The extent of competition for SPE2DB25FYP81 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award